146 related articles for article (PubMed ID: 16195450)
21. Validation of Cdc68p as a novel antifungal target.
Buurman ET; Jiang W; McCoy M; Averett DR; Thompson CM; Wobbe CR
Arch Microbiol; 2002 Dec; 178(6):428-36. PubMed ID: 12420162
[TBL] [Abstract][Full Text] [Related]
22. Clinical trials referral resource. Current clinical trials of 17-AG and 17-DMAG.
Ivy PS; Schoenfeldt M
Oncology (Williston Park); 2004 May; 18(5):610, 615, 619-20. PubMed ID: 15209189
[No Abstract] [Full Text] [Related]
23. How promising are combinatorial drug strategies in combating Candida albicans biofilms?
Thevissen K
Future Med Chem; 2016 Aug; 8(12):1383-5. PubMed ID: 27463947
[No Abstract] [Full Text] [Related]
24. Fungal resistance in Cambodian children with acquired immunodeficiency syndrome.
Krcmery V; Augustinova A; Babelova O; Doczeova A; Liskova A
Pediatr Infect Dis J; 2006 May; 25(5):470. PubMed ID: 16645523
[No Abstract] [Full Text] [Related]
25. The fungal Achilles' heel: targeting Hsp90 to cripple fungal pathogens.
Cowen LE
Curr Opin Microbiol; 2013 Aug; 16(4):377-84. PubMed ID: 23588026
[TBL] [Abstract][Full Text] [Related]
26. Evolution of drug resistance in Candida albicans.
Cowen LE; Anderson JB; Kohn LM
Annu Rev Microbiol; 2002; 56():139-65. PubMed ID: 12142485
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Hsp90 function delays and impairs recovery from heat shock.
Duncan RF
FEBS J; 2005 Oct; 272(20):5244-56. PubMed ID: 16218955
[TBL] [Abstract][Full Text] [Related]
28. Heat shock protein inhibitors for the treatment of fungal infections.
Wirk B
Recent Pat Antiinfect Drug Discov; 2011 Jan; 6(1):38-44. PubMed ID: 21192778
[TBL] [Abstract][Full Text] [Related]
29. CRZ1, a target of the calcineurin pathway in Candida albicans.
Karababa M; Valentino E; Pardini G; Coste AT; Bille J; Sanglard D
Mol Microbiol; 2006 Mar; 59(5):1429-51. PubMed ID: 16468987
[TBL] [Abstract][Full Text] [Related]
30. Drug susceptibilities of yeast cells are affected when expressing mutant Candida albicans drug resistance protein.
Gao PH; Cao YB; Jia XM; Cao YY; Quan H; Wang Y; Jiang YY
Int J Antimicrob Agents; 2006 Jul; 28(1):69-74. PubMed ID: 16782311
[TBL] [Abstract][Full Text] [Related]
31. Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.
Chiosis G; Caldas Lopes E; Solit D
Curr Opin Investig Drugs; 2006 Jun; 7(6):534-41. PubMed ID: 16784024
[TBL] [Abstract][Full Text] [Related]
32. Heat shock protein 90 regulates development in Dictyostelium discoideum.
Sawarkar R; Roy N; Rao S; Raman S; Venketesh S; Suguna K; Tatu U
J Mol Biol; 2008 Oct; 383(1):24-35. PubMed ID: 18718841
[TBL] [Abstract][Full Text] [Related]
33. The Saccharomyces cerevisiae phosphatase activator RRD1 is required to modulate gene expression in response to rapamycin exposure.
Douville J; David J; Lemieux KM; Gaudreau L; Ramotar D
Genetics; 2006 Feb; 172(2):1369-72. PubMed ID: 16322523
[TBL] [Abstract][Full Text] [Related]
34. Hsp90 is involved in apoptosis of Candida albicans by regulating the calcineurin-caspase apoptotic pathway.
Dai B; Wang Y; Li D; Xu Y; Liang R; Zhao L; Cao Y; Jia J; Jiang Y
PLoS One; 2012; 7(9):e45109. PubMed ID: 23028789
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of Hsp90 dimerization modulators.
Chiosis G; Aguirre J; Nicchitta CV
Bioorg Med Chem Lett; 2006 Jul; 16(13):3529-32. PubMed ID: 16621545
[TBL] [Abstract][Full Text] [Related]
36. Physicochemical modification of the excretion product of Saccharomyces cerevisiae killer strains results in fungicidal activity against Candida albicans and Tricophyton mentagrophytes.
Bracesco N; Salvo VA; Carrau FM; Nunes E
FEMS Microbiol Lett; 2006 Mar; 256(1):132-6. PubMed ID: 16487330
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
Ribeiro MA; Paula CR
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
[TBL] [Abstract][Full Text] [Related]
38. Progress and prospects for targeting Hsp90 to treat fungal infections.
Veri A; Cowen LE
Parasitology; 2014 Aug; 141(9):1127-37. PubMed ID: 24560124
[TBL] [Abstract][Full Text] [Related]
39. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors.
Ibrahim NO; Hahn T; Franke C; Stiehl DP; Wirthner R; Wenger RH; Katschinski DM
Cancer Res; 2005 Dec; 65(23):11094-100. PubMed ID: 16322259
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and fungicidal activity of 3,5-dichloropyrazin-2(1H)-one derivatives.
François IE; Cammue BP; Bresseleers S; Fleuren H; Hoornaert G; Mehta VP; Modha SG; Van der Eycken EV; Thevissen K
Bioorg Med Chem Lett; 2009 Aug; 19(15):4064-6. PubMed ID: 19556127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
